245 related articles for article (PubMed ID: 17008700)
1. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose.
Ceresoli GL; Chiti A; Zucali PA; Rodari M; Lutman RF; Salamina S; Incarbone M; Alloisio M; Santoro A
J Clin Oncol; 2006 Oct; 24(28):4587-93. PubMed ID: 17008700
[TBL] [Abstract][Full Text] [Related]
2. Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT.
Schaefer NG; Veit-Haibach P; Soyka JD; Steinert HC; Stahel RA
Eur J Radiol; 2012 Jan; 81(1):e19-25. PubMed ID: 21129871
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
4. Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications.
Lee HY; Hyun SH; Lee KS; Kim BT; Kim J; Shim YM; Ahn MJ; Kim TS; Yi CA; Chung MJ
Ann Surg Oncol; 2010 Oct; 17(10):2787-94. PubMed ID: 20461469
[TBL] [Abstract][Full Text] [Related]
5. What is the best way to diagnose and stage malignant pleural mesothelioma?
Zahid I; Sharif S; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972
[TBL] [Abstract][Full Text] [Related]
6. Malignant pleural mesothelioma presenting as low back pain: diagnosed by bone scan coordinating with F-18 FDG PET/CT.
Huang YC; Tu DG; Wu JD; Lee MY
Spine (Phila Pa 1976); 2009 Oct; 34(21):E780-3. PubMed ID: 19934799
[TBL] [Abstract][Full Text] [Related]
7. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
8. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
Kobayashi N; Fujita K; Fujisawa T; Takahashi H; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Kubota K; Saito S; Nakajima A
Gan To Kagaku Ryoho; 2008 Jan; 35(1):65-70. PubMed ID: 18195530
[TBL] [Abstract][Full Text] [Related]
9. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
10. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
Erasmus JJ; Truong MT; Smythe WR; Munden RF; Marom EM; Rice DC; Vaporciyan AA; Walsh GL; Sabloff BS; Broemeling LD; Stevens CW; Pisters KM; Podoloff DA; Macapinlac HA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1364-70. PubMed ID: 15942579
[TBL] [Abstract][Full Text] [Related]
11. Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.
Szyszko T; Al-Nahhas A; Canelo R; Habib N; Jiao L; Wasan H; Pagou M; Tait P
Nucl Med Commun; 2007 Jan; 28(1):15-20. PubMed ID: 17159544
[TBL] [Abstract][Full Text] [Related]
12. Imaging before and after multimodal treatment for malignant pleural mesothelioma.
Fiore D; Baggio V; Sotti G; Muzzio PC
Radiol Med; 2006 Apr; 111(3):355-64. PubMed ID: 16683083
[TBL] [Abstract][Full Text] [Related]
13. The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases.
Orki A; Akin O; Tasci AE; Ciftci H; Urek S; Falay O; Kutlu CA
Thorac Cardiovasc Surg; 2009 Jun; 57(4):217-21. PubMed ID: 19670115
[TBL] [Abstract][Full Text] [Related]
14. Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer.
Chung MK; Jeong HS; Park SG; Jang JY; Son YI; Choi JY; Hyun SH; Park K; Ahn MJ; Ahn YC; Kim HJ; Ko YH; Baek CH
Clin Cancer Res; 2009 Sep; 15(18):5861-8. PubMed ID: 19737951
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
[TBL] [Abstract][Full Text] [Related]
16. Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma.
Veit-Haibach P; Schaefer NG; Steinert HC; Soyka JD; Seifert B; Stahel RA
Lung Cancer; 2010 Mar; 67(3):311-7. PubMed ID: 19482372
[TBL] [Abstract][Full Text] [Related]
17. Morphologic and functional imaging of malignant pleural mesothelioma.
Yamamuro M; Gerbaudo VH; Gill RR; Jacobson FL; Sugarbaker DJ; Hatabu H
Eur J Radiol; 2007 Dec; 64(3):356-66. PubMed ID: 17954021
[TBL] [Abstract][Full Text] [Related]
18. Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.
Kanemura S; Kuribayashi K; Funaguchi N; Shibata E; Mikami K; Doi H; Kitajima K; Hasegawa S; Nakano T
Eur J Radiol; 2017 Jan; 86():92-98. PubMed ID: 28027772
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy.
Righi L; Papotti MG; Ceppi P; Billè A; Bacillo E; Molinaro L; Ruffini E; Scagliotti GV; Selvaggi G
J Clin Oncol; 2010 Mar; 28(9):1534-9. PubMed ID: 20177021
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM
J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
